Axsome Therapeutics (NASDAQ:AXSM) Upgraded to Hold at StockN

Axsome Therapeutics (NASDAQ:AXSM – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday. AXSM has been the topic of a number of other reports. HC Wainwright reaffirmed a “buy” rating and issued a $200.00 price target on shares of […]

Related Keywords

China , United States , America , , Axsome Therapeutics Inc , Nasdaq , Tower Research Capital , Quent Capital , Morgan Stanley , China Universal Asset Management Co , Armstrong Advisory Group Inc , Axsome Therapeutics , Get Rating , Financial Advisors , Advisory Group , Universal Asset Management , Research Capital , Products Overview , Pipeline Overview , Axsome Therapeutics Daily , Nasdaq Axsm , Axsm , Medical , Upgrade , Stocknews Com ,